HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hyper-eosinophilia in granular acute B-cell lymphoblastic leukemia with myeloid antigen expression.

Abstract
Acute lymphoblastic leukemia with eosinophilia (ALLEo) is a rare but a distinctive clinical entity. Clinical features of idiopathic hyper-eosinophilic syndrome (HES) can be seen in patients with ALLEo. We report a 10-year-old girl, in whom HES was initially suspected but further investigation confirmed the diagnosis of acute B-cell lymphoblastic leukemia with myeloid antigen expression. Clinical response to chemotherapy was excellent with achievement of complete remission for 4 years. Serum interleukin-3 and -5 were elevated at presentation and normalized with disappearance of eosinophilia after induction therapy, supporting the reactive nature of eosinophilia in ALLEo. Hematologic malignancy should be considered in patients with hyper-eosinophilia, before attributing it to HES.
AuthorsDaisuke Kobayashi, Kazuhiro Kogawa, Kohsuke Imai, Toshio Tanaka, Akiko Sada, Shigeaki Nonoyama
JournalPediatrics international : official journal of the Japan Pediatric Society (Pediatr Int) Vol. 54 Issue 4 Pg. 543-6 (Aug 2012) ISSN: 1442-200X [Electronic] Australia
PMID22830543 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2012 The Authors. Pediatrics International © 2012 Japan Pediatric Society.
Chemical References
  • Sialic Acid Binding Ig-like Lectin 3
Topics
  • Child
  • Eosinophilia (complications, immunology)
  • Female
  • Humans
  • Leukemia, B-Cell (complications, immunology)
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma (complications, immunology)
  • Sialic Acid Binding Ig-like Lectin 3 (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: